Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer

by Shenduo Li, Guilherme Sacchi de Camargo Correia, Jing Wang, Rami Manochakian, Yujie Zhao, Yanyan Lou
Published 2023-05-01

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis

by Qinfang Deng, Qiyu Fang, Hui Sun, Aditi P. Singh, Mariam Alexander, Shenduo Li, Haiying Cheng, Songwen Zhou
Published 2020-03-01

Model of tumor dormancy/recurrence after short-term chemotherapy.

by Shenduo Li, Margaret Kennedy, Sturgis Payne, Kelly Kennedy, Victoria L Seewaldt, Salvatore V Pizzo, Robin E Bachelder
Published 2014-01-01

Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunothera...

by Shenduo Li, Rami Manochakian, Ruqin Chen, Jaydeepbhai Patel, Jyothik Varun Inampudi, Koshiya R. Hiren, Yujie Zhao, Yanyan Lou
Published 2024-02-01

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma

by Krishnendu Pal, Tabish Hussain, Hao Xie, Shenduo Li, Ping Yang, Aaron Mansfield, Yanyan Lou, Shantanu Chowdhury, Shantanu Chowdhury, Debabrata Mukhopadhyay
Published 2022-08-01

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

by Blake J. McKinley, Tanmayi S. Pai, Emily B. Wolf, Shenduo Li, Guilherme Sacchi de Camargo Correia, Yujie Zhao, Rami Manochakian, Yanyan Lou
Published 2024-06-01

Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways

by Feng Wang, Ayse Ece Cali Daylan, Lei Deng, Jihua Yang, Janaki Sharma, Christopher Su, Shenduo Li, Xingxing Zang, Balazs Halmos, Alain Borczuk, Haiying Cheng
Published 2023-06-01

First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcin...

by Umair Majeed, MD, Shenduo Li, MD, PhD, Karan Seegobin, MBBS, Aziza Nassar, MD, Rami Manochakian, MD, Yujie Zhao, MD, PhD, Yanyan Lou, MD, PhD
Published 2023-07-01

Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Imm...

by Kang Qin, Kaiwen Wang, Shenduo Li, Lingzhi Hong, Priyadharshini Padmakumar, Rinsurongkawong Waree, Shawna M. Hubert, Xiuning Le, Natalie Vokes, Kunal Rai, Ara Vaporciyan, Don L. Gibbons, John V. Heymach, J. Jack Lee, Scott E. Woodman, Caroline Chung, David A. Jaffray, Mehmet Altan, Yanyan Lou, Jianjun Zhang
Published 2024-02-01

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer

by Lingzhi Hong, Muhammad Aminu, Shenduo Li, Xuetao Lu, Milena Petranovic, Maliazurina B. Saad, Pingjun Chen, Kang Qin, Susan Varghese, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Amy Spelman, Yasir Y. Elamin, Marcelo V. Negrao, Ferdinandos Skoulidis, Carl M. Gay, Tina Cascone, Saumil J. Gandhi, Steven H. Lin, Percy P. Lee, Brett W. Carter, Carol C. Wu, Mara B. Antonoff, Boris Sepesi, Jeff Lewis, Don L. Gibbons, Ara A. Vaporciyan, Xiuning Le, J. Jack Lee, Sinchita Roy-Chowdhuri, Mark J. Routbort, Justin F. Gainor, John V. Heymach, Yanyan Lou, Jia Wu, Jianjun Zhang, Natalie I. Vokes
Published 2023-02-01